Agilent Technologies (NYSE:A) Updates Q4 2026 Earnings Guidance

Posted by Francis Steltz on Aug 26th, 2026

Agilent Technologies (NYSE:A – Get Free Report) issued an update on its fourth quarter 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.710-1.740 for the period, compared to the consensus EPS estimate of 1.710. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion. Agilent Technologies also updated its FY 2026 guidance to 6.180-6.210 EPS.

Agilent Technologies Stock Up 0.3%

Shares of A stock traded up $0.39 during mid-day trading on Wednesday, hitting $155.16. The company’s stock had a trading volume of 3,192,178 shares, compared to its average volume of 2,234,460. Agilent Technologies has a 52-week low of $108.35 and a 52-week high of $160.51. The business has a 50-day moving average price of $138.55 and a 200 day moving average price of $126.47. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a market cap of $43.82 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 2.71 and a beta of 1.25.

Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts predict that Agilent Technologies will post 6.05 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Wells Fargo & Company cut their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Robert W. Baird upped their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Sanford C. Bernstein began coverage on shares of Agilent Technologies in a report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective on the stock. Finally, Jefferies Financial Group began coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price for the company. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Check Out Our Latest Analysis on Agilent Technologies

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

Positive Sentiment: Quarterly results exceeded expectations: Agilent reported revenue of $1.88 billion, up 8.1% year over year and above the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of $1.49, while GAAP net income increased to $362 million, or $1.28 per share. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
Positive Sentiment: Profitability and cash flow improved: Operating profit rose 23.3% to $444 million, and operating cash flow climbed 43.4% to $519 million. The company ended the quarter with $1.8 billion in cash, supporting financial flexibility.
Positive Sentiment: Full-year guidance was raised above consensus: Agilent forecast fiscal 2026 adjusted EPS of $6.18-$6.21, ahead of the $6.06 analyst consensus, and revenue of approximately $7.5 billion versus expectations of roughly $7.4 billion. Fourth-quarter EPS guidance of $1.71-$1.74 was in line to modestly above consensus. Agilent raises annual profit forecast on improving lab tools demand
Neutral Sentiment: Institutional positioning was mixed: Recent filings showed 594 institutions adding shares and 550 reducing positions, indicating continued interest but no clear consensus among large investors.
Neutral Sentiment: Valuation may limit further gains: The stock was trading near its 12-month high, while the median analyst price target was $155, roughly around the recent trading level. This suggests expectations for the improved outlook may already be reflected in the share price.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of A. AQR Capital Management LLC raised its holdings in Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the period. Ameriprise Financial Inc. grew its position in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Morgan Stanley raised its stake in Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after purchasing an additional 692,202 shares during the period. Invesco Ltd. lifted its holdings in Agilent Technologies by 32.0% in the 4th quarter. Invesco Ltd. now owns 2,590,715 shares of the medical research company’s stock worth $352,519,000 after purchasing an additional 627,804 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its stake in Agilent Technologies by 639.4% in the 2nd quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock worth $80,093,000 after purchasing an additional 586,931 shares during the period.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.